OFFICIAL LEGAL TITLE
FDA Modernization Act 2.0
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 117_S_5002.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2022-09-29.
What are the main provisions?
Key points include:
- Permission to use non-animal tests (e.g., cell-based, computer models) for drug safety assessment.
- Potential for faster market introduction of new drugs due to more flexible testing methods.
- Reduction in the number of animals used in laboratory research.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Paul, Rand [R-KY].
What is the latest detailed status?
The latest detailed status is: Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent. (consideration: CR S5514-5515; text: CR S5514-5515)
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.